BTK | Bruton agammaglobulinemia tyrosine kinase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
C17orf53 | Chromosome 17 open reading frame 53 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CCNDBP1 | Cyclin D-type binding-protein 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CD2 | CD2 molecule | CD markers FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CDCA4 | Cell division cycle associated 4 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CEBPE | CCAAT/enhancer binding protein (C/EBP), epsilon | Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
E2F1 | E2F transcription factor 1 | Cancer-related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
FBXO5 | F-box protein 5 | Predicted intracellular proteins
| | | | | Tissue enhanced |
FUT4 | Fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific) | Predicted membrane proteins
| | | | | Tissue enriched |
GRAP2 | GRB2-related adaptor protein 2 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
GSDMC | Gasdermin C | Predicted intracellular proteins
| | | | | Group enriched |
H1FX | H1 histone family, member X | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
HIST1H1E | Histone cluster 1, H1e | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enriched |
HMGA2 | High mobility group AT-hook 2 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
ITGA2B | Integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
KIF18B | Kinesin family member 18B | Predicted intracellular proteins
| | | | | Tissue enhanced |
LRMP | Lymphoid-restricted membrane protein | Cytoskeleton related proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
MKI67 | Marker of proliferation Ki-67 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
MYBL2 | V-myb avian myeloblastosis viral oncogene homolog-like 2 | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
NME8 | NME/NM23 family member 8 | Disease related genes Predicted intracellular proteins
| | | | | Group enriched |
P2RX5 | Purinergic receptor P2X, ligand-gated ion channel, 5 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
RECQL4 | RecQ protein-like 4 | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
RENBP | Renin binding protein | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
SKAP1 | Src kinase associated phosphoprotein 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
SNRPA1 | Small nuclear ribonucleoprotein polypeptide A' | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
SPTB | Spectrin, beta, erythrocytic | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
VCAN | Versican | Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
WAS | Wiskott-Aldrich syndrome | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |